Demystifying the immortality of cancer cells

July 5, 2012
The telomeres can be seen as white dots on these chromosomes© National Institute of Health

(Medical Xpress) -- In cancer cells, normal mechanisms governing the cellular life cycle have gone haywire. Cancer cells continue to divide indefinitely, without ever dying off, thus creating rapidly growing tumors. Swiss scientists have discovered a protein complex involved this deregulated process, and hope to be able to exploit it to stop tumor formation in its tracks.

All our cells come equipped with an automatic self-destruct mechanism; they are programmed to die after a certain number of divisions. This is of great interest to cancer researchers, because most forms of cancer exhibit a defect in this innate timing mechanism. Cancer cells continue to divide indefinitely, long past the moment at which a normal cell would self-destruct. A team of researchers from professor Joachim Lingner’s laboratory at EPFL has learned how this defect is regulated in a . Post-doctoral researcher Liuh-Yow Chen led the team in publishing an article appearing in the journal Nature on the 4th of July 2012. Their hope is that the discovery will provide new targets for drug therapies to combat the deadly disease.

Cellular immortality, which is responsible for cancer formation, hearkens back to a critical function of the cells of the developing embryo. At the ends of every chromosome there is a special sequence of DNA known as a telomere, whose length is governed by the telomerase enzyme. This sequence represents the lifespan of the cell. Every time the cell divides, it is shortened, and when the telomere finally runs out, the cell dies. This reserve allows most cells to divide about 60 times – sufficient for the cell to play its given role in the organism, without succumbing to inevitable genetic mutation.

Cellular immortality, cancer’s common denominator

Normally, once the embryonic stage is completed, our cells stop producing telomerase – with the notable exception of somatic stem cells. But occasionally, a cell will mutate and reactivate production of the enzyme, so that when the cell divides, the telomere gets longer instead of shorter. This is what gives cancer cells their immortality.

“This mutation, on its own, is not enough to cause cancer,” explains Joachim Lingner, co-author and head of the lab. “But cellular immortality is a critical element in in 90% of known cancers.” Researchers the world over hope to be able to stop the runaway growth of cancer cells by targeting this mechanism with drug therapy.

But interestingly enough, even in a cancer cell the telomere doesn’t grow indefinitely long. With each cell division it loses some 60 nucleotides, like most cells, but then the activated telomerase causes it to gain just as many back. The internal clock is reset to zero, and the cell becomes immortal. But there’s one interesting question here: What is stopping the telomere from getting indefinitely long?

Stopping the clock with three proteins

The EPFL team was able to provide an answer to this question; they identified three proteins that join together and then attach themselves to the telomere. A bit like a lid on a pot, this protein complex prevents telomerase from acting on the telomere. But in the cancer cell, their timing is off – their involvement takes place too late.

“If we could cause these proteins to act earlier, or if we could recreate a similar , the cancer cell would no longer be immortal,” explains Ligner. The would die a normal death. Clinical applications are still a long way off, however, he insists. “Our discovery may allow us to identify potential targets - for example, a secondary to which these three proteins also attach. But right now our work is still in the basic research stages.”

Explore further: Alternate ending -- living on without telomerase

Related Stories

Alternate ending -- living on without telomerase

November 3, 2011
Scientists of the German Cancer Research Center have discovered an alternative mechanism for the extension of the telomere repeat sequence by DNA repair enzymes.

Study explores possible 'safe and effective' anti-cancer therapy

February 3, 2012
(Medical Xpress) -- New findings discovered by an international research team, which includes a professor from Western University, may lead to a safe and effective anti-cancer therapy.    A report published online ...

Research reveals how cancer-driving enzyme works

May 6, 2011
Cancer researchers at UT Southwestern Medical Center are helping unlock the cellular-level function of the telomerase enzyme, which is linked to the disease's growth.

Recommended for you

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

Liquid biopsy results differed substantially between two providers

December 14, 2017
Two Johns Hopkins prostate cancer researchers found significant disparities when they submitted identical patient samples to two different commercial liquid biopsy providers. Liquid biopsy is a new and noninvasive alternative ...

Testing the accuracy of FDA-approved and lab-developed cancer genetics tests

December 14, 2017
Cancer molecular testing can drive clinical decision making and help a clinician determine if a patient is a good candidate for a targeted therapeutic drug. Clinical tests for common cancer causing-mutations in the genes ...

Newest data links inflammation to chemo-brain

December 14, 2017
Inflammation in the blood plays a key role in "chemo-brain," according to a published pilot study that provides evidence for what scientists have long believed.

One in five young colon cancer patients have genetic link

December 13, 2017
As doctors grapple with increasing rates of colorectal cancers in young people, new research from the University of Michigan may offer some insight into how the disease developed and how to prevent further cancers. Researchers ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

antialias_physorg
not rated yet Jul 05, 2012
"But right now our work is still in the basic research stages."

But it's finally someone who acts on the root cause for cancer cells. Treatments nowadays are geared towrads highly specific cancer cells. However, if they manage to rectify the telomere/telomerase problem (and find a way to deliver it to cancer cells) then that's the silver bullet for ALL cancer types.
Robert L Mayo
not rated yet Jul 08, 2012
"even in a cancer cell the telomere doesnt grow indefinitely long."

This statement is not correct. 10-15% of cancer cells use a non-telomerase based method of telomere elongation called "alternative lengthening of telomeres pathway" or ALT-pathway. The ALT-pathway produces extreme variability in telomere length up to many thousands of bases. If there is no interdependence between the two pathways, restricting telomerase mediated telomere lengthening would only select for ALT-pathway cancer cells, causing a recurrence of the disease in a telomerase independent form. (Please take this with a grain of salt; I am not a scientist, I just read things.)

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.